Financial report interval: 2025.12.31 - 2026.03.31
Preview: BeOne Medicines(688235) predict that the Revenue is 1.513 B (+35.46%), Beat estimate;the EBIT is 249.9 M (+2151%), Beat estimate;the EPS is 1.96 (--%), Beat estimate.